Organelle acidification and disease

Traffic

Volumn 4, Issue 2, 2003, Pages 57-64

  Weisz, Ora A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Channel; Endosome; Golgi; Protein; V ATPase

Indexed keywords

PROTON PUMP; TAMOXIFEN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ACIDIFICATION; ACIDITY; CANCER GROWTH; CELL COMPARTMENTALIZATION; CELL GROWTH; CELL ORGANELLE; CELL PH; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG MECHANISM; ENDOSOME; GLYCOSYLATION; GOLGI COMPLEX; HOMEOSTASIS; HUMAN; HUMAN CELL; ION CONDUCTANCE; KIDNEY DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROTON TRANSPORT; REVIEW; STEADY STATE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYSTIC FIBROSIS; DRUG RESISTANCE, NEOPLASM; HUMANS; HYDROGEN-ION CONCENTRATION; NEOPLASMS; ORGANELLES; PROTEINURIA;

EID: 0038105847     PISSN: 13989219     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0854.2003.40201.x     Document Type: Review

References (84)

1. Mukherjee S, Ghosh RN, Maxfield FR. Endocytosis. Phys Rev 1997;77:759-803.
2. McCoy KL. Contribution of endosomal acidification to antigen processing. Semin Immunol 1990;2:239-246.
3. +ATPase is required for both endocytic and exocytic processes during viral infection of BHK-21 cells. J Biol Chem 1994;269:17577-17585.
4. Guinea R, Carrasco L. Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J Virol 1995;69:2306-2312.
5. +-ATPase in animal virus entry. J Gen Virol 1994;75:2595-2606.
6. Seksek O, Biwersi J, Verkman AS. Direct measurement of trans-Golgi pH in living cells and regulation by second messengers. J Biol Chem 1995;270:4967-4970.
7. Miesenbock G, De Angelis DA, Rothman JE. Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 1998;394:192-195.
8. Demaurex N, Furuya W, D'Souza S, Bonifacino JS, Grinstein S. Mechanism of acidification of the trans-Golgi network (TGN). In situ measurements of pH using retrieval of TGN38 and furin from the cell surface. J Biol Chem 1998;273:2044-2051.
9. Mellman I, Fuchs R, Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 1986;55:663-700.
10. Weisz OA. Acidification and protein traffic. Int Rev Cytol 2003; in press.
11. Futai M, Oka T, Moriyama Y, Wada Y. Diverse roles of single membrane organelles: factors establishing the acid lumenal pH. J Biochem (Tokyo) 1998;124:259-267.
12. Grabe M, Oster G. Regulation of organelle acidity. J Gen Physiol 2001;117:329-344.
13. +)-ATPase. Annu Rev Cell Dev Biol 1997;13:779-808.
14. + pump in parallel to a chloride conductance. J Cell Biol 1983;97:1303-1308.
15. Xie X-S, Stone DK, Racker E. Determinants of clathrin-coated vesicle acidification. J Biol Chem 1983;258:14834-14838.
16. Arai H, Pink S, Forgac M. Interaction of anions and ATP with the coated vesicle proton pump. Biochemistry 1989;28:3075-3082.
17. Rybak SL, Lanni F, Murphy RF. Theoretical considerations on the role of membrane potential in the regulation of endosomal pH. Biophys J 1997;73:674-687.
18. + 'leak'. J Biol Chem 1991;266: 24540-24548.
19. Marshansky V, Vinay P. Proton gradient formation in early endosomes from proximal tubules. Biochim Biophys Acta 1996;1284:171-180.
20. Barasch J, Gershon MD, Nunez EA, Tamir H, Al-Awqati Q. Thyrotropin induces the acidification of the secretory granules of parafollicular cells by increasing the chloride conductance of the granular membrane. J Cell Biol 1988;107:2137-2147.
21. Wu MM, Grabe M, Adams S, Tsien RY, Moore HP, Machen TE. Mechanisms of pH regulation in the regulated secretory pathway. J Biol Chem 2001;276:33027-33035.
22. Schapiro FB, Grinstein S. Determinants of the pH of the Golgi complex. J Biol Chem 2000;275:21025-21032.
23. van Dyke RW, Belcher JD. Acidification of three types of liver endocytic vesicles: similarities and differences. Am J Physiol 1994;266 (1 Part 1):C81-C94.
24. Uchida S. In vivo role of CLC chloride channels in the kidney. Am J Physiol Renal Physiol 2000;279:F802-F808.
25. Jiang LW, Maher VM, McCormick JJ, Schindler M. Alkalinization of the lysosomes is correlated with ras transformation of murine and human fibroblasts. J Biol Chem 1990;265:4775-4777.
26. +-ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 1993;265 (4 Part 1 ):C1015-C1029.
27. Sparkowski J, Mense M, Anders J, Schlegel R. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. J Virol 1996;70:2420-2430.
28. Straight SW, Herman B, McCance DJ. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J Virol 1995;69:3185-3192.
29. Thomsen P, van Deurs B, Norrild B, Kayser L. The HPV16 E5 oncogene inhibits endocytic trafficking. Oncogene 2000;19:6023-6032.
30. Schapiro F, Sparkowski J, Adduci A, Suprynowicz F, Schlegel R, Grinstein S. Golgi alkalinization by the papillomavirus E5 oncoprotein. J Cell Biol 2000;148:305-315.
31. Oetke C, Auvinen E, Pawlita M, Alonso A. Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation. Arch Virol 2000;145:2183-2191.
32. +-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein. J Biol Chem 1995;270:6830-6837.
33. 1 influence cell motility. Biochim Biophys Acta 1999;1452:285-295.
34. Lothstein L, Israel M, Sweatman TW. Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road. Drug Resist Updat 2001;4:169-177.
35. Ford JM, Hait WN. Pharmacologic circumvention of multidrug resistance. Cytotechnology 1993;12:171-212.
36. Simon SM, Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 1994;91:3497-3504.
37. Simon S, Roy D, Schindler M. Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci USA 1994;91:1128-1132.
38. Schindler M, Grabski S, Hoff E, Simon SM. Defective pH regulation of acidic compartments in human breast cancer cells (MCF-7) is normalized in adriamycin-resistant cells (MCF-7 adr). Biochemistry 1996;35:2811-2817.
39. Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 1998;187:1583-1598.
40. Altan N, Chen Y, Schindler M, Simon SM. Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc Natl Acad Sci USA 1999;96:4432-4437.
41. Chen Y, Schindler M, Simon SM. A mechanism for tamoxifen-mediated inhibition of acidification. J Biol Chem 1999;274:18364-18373.
42. Wrong OM, Norden AG, Feest TG. Dent's disease: a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. Q J Med 1994;87:473-493.
43. Fisher SE, Black GC, Lloyd SE, Hatchwell E, Wrong O, Thakker RV, Craig IW. Isolation and partial characterization of a chloride channel gene which is expressed in kidney and is a candidate for Dent's disease (an X-linked hereditary nephrolithiasis). Hum Mol Genet 1994;3: 2053-2059.
44. Fisher SEBI, Lloyd SE, Pearce SH, Thakker RV, Craig IW. Cloning and characterization of CLCN5, the human kidney chloride channel gene implicated in Dent disease (an X-linked hereditary nephrolithiasis). Genomics 1995;29:598-606.
45. Jentsch TJ, Stein V, Weinreich F, Zdebik AA. Molecular structure and physiological function of chloride channels. Physiol Rev 2002;82: 503-568.
46. Luyckx VA, Goda FO, Mount DB, Nishio T, Hall A, Hebert SC, Hammond TG, Hall AS. Intrarenal and subcellular localization of rat CLC5. Am J Physiol 1998;275 (5 Part 2):F761-F769.
47. Devuyst O, Christie PT, Courtoy PJ, Beauwens R, Thakker RV. Intra-renal and subcellular distribution of the human chloride channel, CLC-5, reveals a pathophysiological basis for Dent's disease. Hum Mol Genet 1999;8:247-257.
48. +-ATPase. Am J Physiol 1999;277 (6 Part 2):F957-F965.
49. Gunther W, Luchow A, Cluzeaud F, Vandewalle A, Jentsch TJ. CIC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci USA 1998;95:8075-8080.
50. - channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 2000;408:369-373.
51. Marshansky V, Ausiello DA, Brown D. Physiological importance of endosomal acidification: potential role in proximal tubulopathies. Curr Opin Nephrol Hypertens 2002;11:527-537.
52. Jilling T, Kirk KL. The biogenesis, traffic, and function of the cystic fibrosis transmembrane conductance regulator. Int Rev Cytol 1997;172:193-241.
53. Barasch J, Kiss B, Prince A, Saiman L, Gruenert D, Al-Awqati Q. Defective acidification of intracellular organelles in cystic fibrosis. Nature 1991;352:70-73.
54. Barasch J, Al-Awqati Q. Defective acidification of the biosynthetic pathway in cystic fibrosis. J Cell Sci Suppl. 1993;17:229-233.
55. Scanlin TF, Glick MC. Terminal glycosylation in cystic fibrosis. Biochim Biophys Acta 1999;1455:241-253.
56. Kellokumpu S, Sormunen R, Kellokumpu I. Abnormal glycosylation and altered Golgi structure in colorectal cancer: dependence on intra-Golgi pH. FEBS Lett 2002;516:217-224.
57. Saiman L, Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 1993;92:1875-1880.
58. Devaraj N, Sheykhnazari M, Warren WS, Bhavanandan VP. Differential binding of Pseudomonas aeruginosa to normal and cystic fibrosis tracheobronchial mucins. Glycobiology 1994;4:307-316.
59. Imundo L, Barasch J, Prince A, Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci USA 1995;92:3019-3023.
60. Dho S, Grinstein S, Foskett JK. Plasma membrane recycling in CFTR-expressing CHO cells. Biochim Biophys Acta 1993;1225:78-82.
61. Biwersi J, Emans N, Verkman AS. Cystic fibrosis transmembrane conductance regulator stimulates endosome fusion in vivo. Proc Natl Acad Sci USA 1996;93:12484-12489.
62. Seksek O, Biwersi J, Verkman AS. Evidence against defective trans-Golgi acidification in cystic fibrosis. J Biol Chem 1996;271:15542-15548.
63. Root KV, Engelhardt JF, Post M, Wilson JM, van Dyke RW. CFTR does not alter acidification of L cell endosomes. Biochem Biophys Res Commun 1995;205:396-401.
64. Dunn KW, Park J, Semrad CE, Gelman DL, Shevell T, McGraw TE. Regulation of endocytic trafficking and acidification are independent of the cystic fibrosis transmembrane regulator. J Biol Chem 1994; 269:5336-5345.
65. Frates RC, Kaizu TT, Last JA. Mucus glycoproteins secreted by respiratory epithelial tissue from cystic fibrosis patients. Pediatr Res 1983;17:30-34.
66. Lamblin G, Lhermitte M, Klein A, Houdret N, Scharfman A, Ramphal R, Roussel P. The carbohydrate diversity of human respiratory mucins: a protection of the underlying mucosa. Am Rev Respir Dis 1991;144: S19-S24.
67. Rose MC. Mucins structure, function, and role in pulmonary diseases. Am J Physiol 1992;263:L413-L429.
68. Engelhardt JF, Zepeda M, Cohn JA, Yankaskas JR, Wilson JM. Expression of the cystic fibrosis gene in adult human lung. J Clin Invest 1994;93:737-749.
69. Cohn LA, Adler KB. Interactions between airway epithelium and mediators of inflammation. Exp Lung Res 1992;18:299-322.
70. Houdret N, Perini J-M, Galabert C, Scharfman A, Humbert P, Lamblin G, Roussel P. The high lipid content of respiratory mucins in cystic fibrosis is related to infection. Biochim Biophys Acta 1986;880:54-61.
71. Bryan R, Kube D, Perez A, Davis P, Prince A. Overproduction of the CFTR R domain leads to increased levels of asialoGM1 and increased Pseudomonas aeruginosa binding by epithelial cells. Am J Respir Cell Mol Biol 1998;19:269-277.
72. Kube D, Adams L, Perez A, Davis PB. Terminal sialylation is altered in airway cells with impaired CFTR-mediated chloride transport. Am J Physiol Lung Cell Mol Physiol 2001;280:L482-L492.
73. Reid CJ, Burdick MD, Hollingsworth MA, Harris A. CFTR expression does not influence glycosylation of an epitope-tagged MUC1 mucin in colon carcinoma cell lines. Glycobiology 1999;9:389-398.
74. Jiang X, Hill WG, Pilewski JM, Weisz OA. Glycosylation differences between a cystic fibrosis and rescued airway cell line are not CFTR dependent. Am J Physiol 1997;273:L913-L920.
75. Gibson GA, Hill WG, Weisz OA. Evidence against the acidification hypothesis in cystic fibrosis. Am J Physiol Cell Physiol 2000;279: C1088-C1099.
76. Chandy G, Grabe M, Moore HP, Machen TE. Proton leak and CFTR in regulation of Golgi pH in respiratory epithelial cells. Am J Physiol Cell Physiol 2001;281:C908-C921.
77. Machen TE, Chandy G, Wu M, Grabe M, Moore HP. Cystic fibrosis transmembrane conductance regulator and H (+) permeability in regulation of Golgi pH. J Pancreas 2001;2 (4 Suppl.):229-236.
78. Poschet JF, Boucher JC, Tatterson L, Skidmore J, van Dyke RW, Deretic V. Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung. Proc Natl Acad Sci USA 2001;98:13972-13977.
79. Poschet JF, Skidmore J, Boucher JC, Firoved AM, van Dyke RW, Deretic V. Hyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cells. J Biol Chem 2002;277:13959-13965.
80. Schwiebert EM, Benos DJ, Egan ME, Stutts MJ, Guggino WB. CFTR is a conductance regulator as well as a chloride channel. Phys Rev 1999;79:S146-S166.
81. Henkel JR, Apodaca G, Altschuler Y, Hardy S, Weisz OA. Selective perturbation of apical membrane traffic by expression of influenza virus M2, an acid-activated ion channel, in polarized Madin-Darby canine kidney cells. Mol Biol Cell 1998;8:2477-2490.
82. Peters C, Bayer MJ, Bühler S, Andersen JS, Mann M, Mayer A. Trans-complex formation by proteolipid channels in the terminal phase of membrane fusion. Nature 2001;409:581-588.
83. Geyer M, Fackler OT, Peterlin BM. Subunit H of the V-ATPase involved in endocytosis shows homology to β-adaptins. Mol Biol Cell 2002;13:2045-2056.
84. Bradbury NA. Intracellular CFTR: localization and function. Phys Rev 1999;79:S175-S191.